References
- Fu J Y, Masferrer J L, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990; 265: 16737–16740, [PUBMED], [INFOTRIEVE]
- Sousa A, Pfister R, Christie P E, Lane S J, Nasser S M, Schmitz‐Schumann M, Lee T H. Enhanced expression of cyclo‐oxygenase isoenzyme 2 (COX‐2) in asthmatic airways and its cellular distribution in aspirin‐sensitive asthma. Thorax 1997; 52: 940–945, [PUBMED], [INFOTRIEVE]
- Stevenson D D, Sanchez‐Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma & Immun 2001; 87: 177–180, [CSA]
- Stevenson D D, Simon R A, Zuraw B A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. Middleton: Allergy: Principles and Practice6th ed., N F Adkinson, Jr, J W Yunginger, W W Busse, B S Bochner, S T Holgate, F E Simon. Mosby and Co, St. Louis 2003; 1695–1710
- Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin‐like drugs. Nat New Biol 1971; 231: 232–235, [PUBMED], [INFOTRIEVE]
- Vane J R. The mode of action of aspirin and similar compounds. J Allergy Clin Immunol 1976; 58: 691–712, [PUBMED], [INFOTRIEVE]
- Szczeklik A, Gryglewski R J, Czerniawska‐Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin‐sensitive patients. Br Med J 1975; 1: 60–67
- Takimoto C H, Lynch D, Stulbarg M S. Pulmonary infiltrates associated with sulindac therapy. Chest 1990; 230–234
- Quiralte J, Blanco C, Castillo R, Ortego N, Carrilo T. Anaphylactoid reactions due to NSAIDs: clinical and cross‐reactivity studies. Ann Allergy Asthma & Immun 1997; 78: 293–296, [CSA]
- Bigby M, Stern R. Cutaneous reactions to nonsteroidal antiinflammatory drugs. J Am Acad Dermatol 1985; 12: 866–876, [PUBMED], [INFOTRIEVE]
- Berges Gimeno M P, Simon R A, Stevenson D D. The natural history and clinical characteristics of aspirin‐exacerbated respiratory disease. Ann Allergy Asthma & Immun 2002; 89: 474–478, [CSA]
- Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin induced asthma. AIANE investigators. European network on aspirin‐induced asthma. Eur Respir J 2000; 16: 432–436, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pleskow W W, Stevenson D D, Mathison D A, Simon R A, Schatz M, Zeiger R S. Aspirin‐sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983; 71: 574–579, [PUBMED], [INFOTRIEVE], [CSA]
- Marquette C H, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq J M, et al. Long‐term prognosis for near‐fatal asthma. A 6‐year follow‐up study of 145 asthmatic patients who underwent mechanical ventilation for near‐fatal attack of asthma. Am Rev Respir Dis 1992; 146: 76–81, [PUBMED], [INFOTRIEVE]
- Czerniawska‐Mysik G, Szczeklik A. Idiosyncrasy to pyrazolone drugs. Allergy 1981; 36: 381–384
- Quiralte J, Blanco M, Castillo R, Ortega N, Camillo T. Anaphylactoid reactions due to NSAIDs: clinical and cross‐reactivity studies. Ann Allergy Asthma & Immun 1997; 78: 293–296
- Vanselow N A, Smith J R. Bronchial asthma induced by indomethacin. Ann Intern Med 1967; 66: 568–573, [PUBMED], [INFOTRIEVE]
- Samter M, Beers R, Jr. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68: 975–983, [PUBMED], [INFOTRIEVE]
- Mathison D A, Stevenson D D. Hypersensitivity to non‐steroidal anti‐inflammatory drugs: indications and methods for oral challenge. J Allergy Clin Immunol 1979; 64: 669–674, [PUBMED], [INFOTRIEVE]
- Mathison D A, Lumry W R, Stevenson D D. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol 1982; 69: 135
- Pleskow W W, Stevenson D D, Mathinson D A, Simon R A, Schatz M, Zeiger R S. Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982; 69: 11–19, [PUBMED], [INFOTRIEVE]
- Szczeklik A, Gryglewski R J, Czerniawska‐Mysik G. Clinical patterns of hypersensitivity to non‐steroidal anti‐inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977; 60: 276–284, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Settipane R A, Shrank P J, Simon R A, Mathison D A, Christensen S C, Stevenson D D. Prevalence of cross‐sensitivity with acetaminophen in aspirin‐sensitive asthmatic subjects. J Allergy Clin Immunol 1995; 96: 480–485, [PUBMED], [INFOTRIEVE], [CSA]
- Stevenson D D, Hougham A, Shrank P, Goldlust B, Wilson R. Disalcid cross‐sensitivity in aspirin sensitive asthamtics. J Allergy Clin Immunol 1990; 86: 749–758, [PUBMED], [INFOTRIEVE]
- Smith W L. Cyclooxygenase enzymes; a review. Adv Immunol 1996; 62: 167–215, [PUBMED], [INFOTRIEVE], [CSA]
- Szczeklik A, Nizankowska E, Bochenek G, et al. Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma. Clin Exp Allergy 2001; 31: 219–225, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stevenson D D, Simon R A. Lack of cross‐reactivity between rofecoxib and aspirin sensitive asthmatic patients. J Allergy Clin Immunol 2001; 108: 47–51, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Martin‐Garcia C, Hinojosa M, Berges P, et al. Safety of cyclooxygenase‐2 inhibitor in patients with aspirin‐sensitive asthma. Chest 2002; 121: 1812–1817, [CROSSREF]
- Yoshida S, Ischizati Y, Onuma K, Shoji T, Nakayawa H, Amayasu H. Selective cyclo‐oxigenase 2 inhibitor in patients with aspirin‐induced asthma. J Allergy Clin Immunol 2000; 106: 1201–1202, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Woessner K M, Simon R A, Stevenson D D. The safety of celecoxib in patients with aspirin‐sensitive asthma. Arthritis Rheum 2002; 46: 2201–2206, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gylfors P, Bochenek G, Overholt J, Drupka D, et al. Biochemical and clinical evidence that aspirin‐intolerant asthmatic subjects tolerate the cyclooxygenase 2‐selective anlgesic drug celecoxib. J Allergy Clin Immunol 2003; 111: 1116–1121, [CROSSREF], [CSA]
- Asero R. Tolerability of rofecoxib. Allergy 2001; 56: 916–917, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sanchez‐Borges M, Capriles‐Hulett A, Caballero F, Perz C. Tolerance to COX‐2 inhibitors in patients with NSAID‐induced urticaria/angioedema. Ann Allergy Asthma & Immun 2001; 87: 201–204, [CSA]
- Berges‐Gimeno M P, Camacho‐Garrido E, Garcia‐Rodriguez R M, Alfaya T, Martin‐Gacìa C, Hinojosa M. Rofecoxib: safe in NSAIDs intolerant patient. Allergy 2001; 56: 1017–1018, [CROSSREF]
- Garcia‐Rodriguez R, Hinojosa M, Camacho E, Berges‐Gimeno P, et al. Celecoxib: safe in NSAIDs intolerance. Allergy 2002; 57: 1085–1086, [CROSSREF], [CSA]
- Pacor M L, DiLorenzo G, Biasi D, Barbagallo M, Corrocher R. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and or NSAIDs. Clin Exp Allergy 2002; 32: 397–400, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nettis E. Tolerability of rofecoxib in patients with cutaneous reactions to NSAIDs. Ann Allergy Asthma & Immun 2002; 88: 331–334
- Quiralte J, Saenz de San B, Florido J J. Safety of slective COX‐2 inhibitor rofecoxib in patients with NSAID‐induced cutaneous reactions. Ann Allergy Asthma & Immun 2002; 89: 63–66, [CSA]
- Woessner K M, Simon R A, Stevenson D D. Monosodium glutamate (MSG) sensitivity in asthma. J. Allergy Clin Immunol 1999; 104: 305–310, [PUBMED], [INFOTRIEVE], [CSA]
- Simon R A, Stevenson D D. Adverse reactions to food and drug additives. Allergy: Principles and Practice, E Middleton, Jr, E F Ellis, J W Yunginger, C E Reed, N F Adkinson, Jr, W W Busse. Mosby, St. Louis 1993; 1687–1704
- Widal M F, Abrami P, Lermeyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922; 30: 189–192
- Zeiss C R, Lockey R F. Refractory period to aspirin in a patient with aspirin‐induced asthma. J Allergy Clin Immunol 1976; 57: 440–448, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stevenson D D, Simon R A, Mathison D A. Aspirin‐sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980; 66: 82–88, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stevenson D D. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol 2003; 24: 159–167, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Szczeklik A, Gryglewski R J, Nizankowska E. Asthma relieved by aspirin and by other cyclo‐oxygenase inhibitors. Thorax 1978; 33: 664–665, [PUBMED], [INFOTRIEVE]
- Lockey R F. Aspirin‐improved ASA triad. Hosp Pract 1978; 13: 129–133
- Chiu J T. Improvement in aspirin‐sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM). J Allergy Clin Immunol 1983; 71: 560–567, [PUBMED], [INFOTRIEVE]
- Lumry W R, Curd J G, Zeiger R S, Pleskow W W, Stevenson D D. Aspirin‐sensitive rhinosinusitis: the clinical syndrome and the effects of aspirin administration. J Allergy Clin Immunol 1983; 71: 580–587, [PUBMED], [INFOTRIEVE], [CSA]
- Stevenson D D, Pleskow W W, Simon R A, Mathinson D A, et al. Aspirin sensitive rhinosinusitis‐asthma: a double‐blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500–507, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Naeije N, Bracamonte M, Michel O, Sergysles R, Duchateau J. Effects of chronic aspirin ingestion in aspirin‐intolerant asthmatic patients. Ann Allergy Asthma & Immun 1984; 53: 262–267
- Nelson R P, Stablein J J, Lockey R F. Asthma improved by acetylsalicylic and other nonsteroidal anti‐inflammatory agents. NER Allergy Proc 1986; 7: 117–121, [PUBMED], [INFOTRIEVE]
- Sweet J M, Stevenson D D, Mathinson D A, Simon R A. Long term effects of aspirin (ASA) desensitization treatmen for ASA sensitive rhinosinusitis/asthma. J Allergy Clin Immunol 1990; 85: 59–65, [PUBMED], [INFOTRIEVE], [CSA]
- Stevenson D D, Hankammer M A, Mathison D A, Christiansen S C, Simon R A. Aspirin desensitization treatment of aspirin sensitive patients with rhinosinusitis‐asthma: long‐term outcomes. J Allergy Clin Immunol 1996; 98: 751–758, [PUBMED], [INFOTRIEVE]
- Berges‐Gimeno M P, Simon R A, Stevenson D D. Long‐term treatment with aspirin desensitization in asthmatic patients with aspirin‐exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111: 180–186, [CSA]
- Kowalski M L, Grzelewska‐Rzymowska I, Szmidt M, Rozniecki J. Clinical efficacy of aspirin in “desensitised” aspirin‐sensitive asthmatics. Eur J Respir Dis 1986; 69: 219–225, [PUBMED], [INFOTRIEVE]
- Berges‐Gimeno M P, Simon R A, Stevenson D D. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin‐exacerbated respiratory disease. Ann Allergy Asthma & Immun 2003; 90: 338–341
- Mathison D A, Lumry W R, Stevenson D D, et al. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol 1982; 69: 135
- Wong J T, Nagy C S, Steven J K, Krinzman S J, Maclean J A, Bloch K J. Rapid oral challenge‐desensitization for patients with aspirin‐related urticaria‐angioedema. J Allergy Clin Immunol 2000; 105: 997–1001, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]